Summary
Adds the Digital Health Advisory Committee to U.S. Food and Drug Administration’s list of standing advisory committees. The committee provides advice on digital health technologies, including Artificial Intelligence/Machine Learning-enabled devices, remote patient monitoring, clinical decision support, and clinical trial technologies.
Healthcare Implications
Signals ongoing U.S. Food and Drug Administration engagement on AI and digital health issues affecting device evaluation and post‑market policies. Clinicians and developers can anticipate structured public input on digital health topics.